De Mattos-Aruda et al. (2018) [69], using the high-depth targeted sequencing of 254 genes frequently mutated in HER2-positive breast cancer and/or related to DNA repair, demonstrated significant spatial and temporal genetic heterogeneity between primary breast tumors and their BMs. This evidence concerns the gene ERBB2 and breast carcinoma.